Ognyan Gatsev

Dr. Ognyan Gatsev


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
Alberto TrinchieriAlberto Trinchieri
Alberto Trinchieri
KAKhalid Mohammed Abdelrahman
Khalid Mohammed Abdelrahman
KBKamran Hassan Bhatti
Kamran Hassan Bhatti
Jibril BelloJibril Bello
Jibril Bello
KDKrishanu Das
Krishanu Das
NBNoor Buchholz
Noor Buchholz
Objective: To evaluate spectrum and resistance rates to antibacterial agents in causative pathogens of bacterial prostatitis in patients from Southern Europe, the Middle East, and Africa. Materials: 1027 isolates from cultures of urine or expressed prostatic secretion, post-massage urine or seminal fluid, or urethral samples were considered. Results: Escherichia coli (32%) and Enterococcus spp. (21%) were the most common isolates. Other Gram-negative, Gram-positive, and atypical pathogens accounted for 22%, 20%, and 5%, respectively. Resistance was <15% for piperacillin/tazobactam and carbapenems (both Gram-negative and -positive pathogens); <5% for glycopeptides against Gram-positive; 7%, 14%, and 20% for aminoglycosides, fosfomycin, and macrolides against Gram-negative pathogens, respectively; 10% for amoxicillin/clavulanate against Gram-positive pathogens; <20% for cephalosporins and fluoroquinolones against to Gram-negative pathogens (higher against Gram-positive pathogens); none for macrolides against atypical pathogens, but 20% and 27% for fluoroquinolones and tetracyclines. In West Africa, the resistance rates were generally higher, although the highest rates for ampicillin, cephalosporins, and fluoroquinolones were observed in the Gulf area. Lower rates were observed in Southeastern Europe. Conclusions: Resistance to antibiotics is a health problem requiring local health authorities to combat this phenomenon. Knowledge of the spectrum of pathogens and antibiotic resistance rates is crucial to assess local guidelines for the treatment of prostatitis.

1 April 2024 in Journal of Endourology and Minimally Invasive Surgery
Verified
Journal Article
Closed access
OGOgnyan Gatsev
Ognyan Gatsev
VTViktoria Todorova
Viktoria Todorova
KHKonstantin Hristov
Konstantin Hristov
KPKremena Petkova
Kremena Petkova
ISIliya Saltirov
Iliya Saltirov
DPDaniela Petrova
Daniela Petrova
Introduction: Prostate cancer remains a formidable health challenge, demanding diagnostic strategies that balance accuracy and invasiveness. To enhance early detection and accurate risk stratification, various diagnostic methods have been developed. Magnetic Resonance Imaging (MRI) is considered the standard imaging modality for the detection and localization of prostate cancer. Prostate Imaging Reporting and Data System (PI-RADS) is a standardized system that assigns scores to suspicious lesions based on MRI findings. This system helps distinguish the likelihood of clinically significant prostate cancer (CsPCa), guiding clinicians in decision-making. Magnetic Resonance Imaging/Ultrasound-Guided fusion target biopsy (MRI/US) has emerged as a promising technique in diagnosis of prostate cancer, fusing advanced imaging modalities with real-time ultrasound guidance. Material and methods: A retrospective study was carried out from January 2019 to June 2023. Patients included in the study had elevated tPSA levels and underwent MRI of the prostate. MRI findings were characterized on the basis of PIRADS grading. All patients with a score equal or higher than PI-RADS 3 underwent MRI/US-guided fusion target biopsy. The histopathological results were retrospectively analyzed. Results: 375 patients were included in the study. The mean age of the patients in our study was 67.8 ± 8.2 years. tPSA levels ranged 17.21 ± 31.36 ng/ml and mean prostate volume was 52.67 ± 19.6 cc. 87.5 % of the patients had a negative rectal digital exam and 12.5 % had a positive one. 29.4 % of the MRI exams had lesions scored as PI-RADS 3, 47.1 % – as PI-RADS 4 and 22.5 % as PI-RADS 5. 67.1 % of detected lesions were located in the peripheral zone, 26.5 % – in the transitional zone, 4.5 % in the anterior zone and 1.6% of the lesions were apical. 35.7 % patients had a negative for carcinoma histopathological result and were diagnosed with benign prostatic hyperplasia; 39.2 % of the histopathological results were classified as low grade prostate carcinoma and 29.5 % as high grade prostate carcinoma. All results were classified according to the Gleason score. 30.1 % were Gleason score 3+3=6, 25.1 % were Gleason 7 (13.1 % as Gleason 3+4 and 12 % as 4+3), 5.1 % were Gleason 8 and 5.6 % were Gleason 4+5 or 5+4. Conclusion: The integration of MRI/US fusion biopsy into the diagnostic pathway has significantly improved the detection and characterization of clinically significant prostate cancer. This approach enables more personalized and precise management strategies for patients with prostate cancer.

1 November 2022
Verified
Journal Article
Closed access
OGOgnyan Gatsev
Ognyan Gatsev
VTViktoria Todorova
Viktoria Todorova
KHKonstantin Hristov
Konstantin Hristov
PPPetar Petrov
Petar Petrov
KPKremena Petkova
Kremena Petkova
ISIliya Saltirov
Iliya Saltirov
Introduction and objective: Management of large impacted proximal ureteral stones is often challenging due to the presence of mucosal edema, inflammation and angulations of the ureter and other factors which impede stone access, visibility and lithotripsy and can lead to different types of complications. The objective of our study is to compare the efficacy and safety of minimally invasive percutaneous nephrolithotripsy (mini-PCNL) and ureteroscopy (URS) in the treatment of impacted proximal ureteral stones. Material and methods: The medical records of 345 patients with impacted proximal ureteral stones 10-20 mm, treated between January 2016 – November 2022 were retrospectively reviewed. 178 patients (51.6%) underwent mini-PCNL, and 167 (48.4%) – URS. Data on patients’ preoperative characteristics, stone-free rates, operating times, intra- and postoperative complications were compared. Results: Patients’ preoperative characteristics were comparable between the two groups, except for mean stone surface and stone size, which were significantly higher in the mini-PCNL group (respectively, 137.87±44.32mm2 vs 80.94±29.66mm2, p=0.000; and 15.03±2.43 vs 12.02±2.22mm, p=0.000). The stone free rate after single procedure was 94.9% for mini-PCNL and 89,3% in the URS group (p=0,116). Four patients (2.3%) in the mini-PCNL group had significant hemorrhage necessitating selective renovasography and angioembolization of AV fistula. 21 (12.5%) patients had stones showing upward migration during the URS procedure and 3 (1.8%) had partial perforation of the ureteral wall. Hemoglobin drop was significantly higher in mini-PNL group (13.58±12.79g/l vs 4.69±5.72g/l, p=0,000). Mean operative time was significantly longer in the URS group, despite the smaller size of the stones (respectively, 41.41±13.62min vs. 30.67±10.34min, p=0,000). There were statistically significant difference of the necessity of auxiliary procedures in the URS group (respectively, 78 patients (46,4%) vs 6 patients (3.6%), p=0.000). Conclusions: For an impacted, proximal ureteral stone mini-PNL had better stone-free rates, shorter operative time and low percentage of auxiliary procedure and hospitalizations. However, URS had the advantages of less invasiveness procedure and shorter postoperative hospital stay.

29 June 2025 in Proceedings of the Bulgarian Academy of Sciences
Verified
Journal Article
Open access
PDF file
SSSofiyanski Sofiyanski
Sofiyanski Sofiyanski
SSSonya Sergieva
Sonya Sergieva
BRBozhil Robev
Bozhil Robev
MDMilena Dimcheva
Milena Dimcheva
OGOgnyan Gatsev
Ognyan Gatsev
ISIliya Saltirov
Iliya Saltirov
Dynamic renal scintigraphy with 99m Technetium diethylenetriaminepentaacetic acid (99mTc-DTPA) is a generally used imaging technique for evaluating renal function of patients with various nephro-urological conditions. However, the application of SPECT/CT is not regularly performed as a part of the study. The aim of the study was to evaluate the added value of SPECT/CT imaging to dynamic renal scintigraphy with 99m Tc-DTPA. Thirty-eight patients – 23 females (60.5%) and 15 males (39.5%), aged 16–83 years (mean: 55.4, standard deviation: 18.76) underwent dynamic nephroscintigraphy with subsequent SPECT/CT. The CT scan was performed with a low dose protocol. A dose of 185 MBq (5 mCi) 99m Tc-DTPA was administered intravenously. Our analysis demonstrated impaired relative renal function in various degrees of left kidney in 21 patients (55.3%) and of right kidney in 17 patients (44.7%). SPECT/CT maging revealed the specific cause, responsible for the renal dysfunction in the cases. The hybrid imaging demonstrated calculosis in 11 patients, urological cancer in 6 patients, postoperative strictures of ureter in five patients, external compression of ureter from ovarian cyst in one patient and compression of ureter due to nephroptosis in one patient as a possible obstructive cause. In 14 patients congenital renal anomalies were the identified causes of impaired renal function – hypoplastic kidney in five patients, duplex kidney in three patients, multiple cortical cysts in three patients, aberrant vessel obstructing the pyelo-ureteral segment in two patients and horseshoe kidney in one patient. The combination of conventional 99m Tc-DTPA dynamic renal scintigraphy with subsequent SPECT/CT could provide not only functional but also anatomical information of the urinary tract, especially in the valuation of obstructive uropathies and congenital renal abnormalities that can change the clinical management.

30 April 2025 in Journal of Endourology and Minimally Invasive Surgery
Verified
Journal Article
Closed access
MUMilitary Medical Academy Clinic Of Urology
Military Medical Academy Clinic Of Urology
OGOgnyan Gatsev
Ognyan Gatsev
VTViktoria Todorova
Viktoria Todorova
KHKonstantin Hristov
Konstantin Hristov
KPKremena Petkova
Kremena Petkova
ISIliya Saltirov
Iliya Saltirov
INTRODUCTION: Management of large impacted proximal ureteral stones is often challenging due to the presence of mucosal edema, inflammation and angulations of the ureter and other factors which impede stone access, visibility and lithotripsy and can lead to different types of complications. The objective of our study is to compare the efficacy and safety of minimally invasive percutaneous nephrolithotripsy (mini-PNL) and retrograde intrarenal surgery (RIRS) with FANS in the treatment of impacted proximal ureteral stones. MATERIAL AND METHOD: The medical records of 94 patients with impacted proximal ureteral stones 10-15 mm, treated between January 2020 – December 2024 were retrospectively reviewed. 43 patients (45.7%) underwent mini-PNL, and 51 (54.3%) – RIRS with FANS. Data on patients’ preoperative characteristics, stone-free rates, operating times, intra- and postoperative complications were compared. Findings: Patients’ preoperative characteristics were comparable between the two groups, except for preoperative level of Hemoglobin and Stone Density (HU), which were significantly higher in the mini-PNL group (respectively, 147,3 ± 14,2g/l vs 127,4 ± 14,7 g/l, p=0.000; and 1151,9±170,8vs 1060,4±70,3, p=0.001).Thestone free rate after single procedure was 93.0% for mini-PNL and 86,3% in the RIRS group (p=0,335). One patient (2.3%) in the mini-PNL group had significant hemorrhage necessitating selective renovasography and angioembolization of AV fistula and additional hemotransfusion. 3 (5,9%) patients had fever > 38,5oC postoperatively in RIRS group. Mean operative time was significantly longer in the RIRS group, despite the smaller size of the stones (respectively, 42,2±4,6min vs. 24,6±7,4min, p=0,000). There were statistically significant difference of the necessity of auxiliry procedures in the RIRS group (respectively, 34 patients (68,5%) vs 9 patients (20,8%), p=0.000). Conclusion: Both RIRS with FANS and mini-PCNL are effective for managing proximal ureteral stones. Mini-PNL had better stone-free rates, shorter operative time and low percentage of auxiliary procedure and hospitalizations. However, fURS with FANS had the advantages of less invasiveness procedure and shorter postoperative hospital stay. Personalized treatment planning, taking into account patient and stone characteristics, is essential to optimize outcomes.